ID | 116020 |
タイトル別表記 | Super responder of critical COVID-19 case
|
著者 |
Kishaba, Tomoo
Okinawa Chubu Hospital
Maeda, Akiko
Okinawa Chubu Hospital
Fukuoka, Shou
Okinawa Chubu Hospital
Imai, Toru
Okinawa Chubu Hospital
Takakura, Shunichi
Okinawa Chubu Hospital
Yokoyama, Shuhei
Okinawa Chubu Hospital
Shiiki, Soichi
Okinawa Chubu Hospital
Narita, Masashi
Okinawa Chubu Hospital
Nabeya, Daijiro
Okinawa Chubu Hospital
Nagano, Hiroaki
Okinawa Chubu Hospital
|
キーワード | ARDS
COVID-19
methylprednisolone
PCR
tocilizumab
|
資料タイプ |
学術雑誌論文
|
抄録 | This report presents a case of a 74-year-old man who showed dramatic therapeutic response to treatment of coronavirus infectious disease-19 (COVID-19) pneumonia. He reported four-day history of sustained fever and acute progressive dyspnea. He developed severe respiratory failure, underwent urgent endotracheal intubation and showed marked elevation of inflammatory and coagulation markers such as c-reactive protein (CRP), ferritin, lactate dehydrogenase (LDH) and D-dimer. Chest computed tomography (CT) demonstrated diffuse consolidation and ground glass opacity (GGO). We diagnosed critical COVID-19 pneumonia with detailed sick contact history and naso-pharyngeal swab of a reverse-transcriptase-polymerase-chain reaction (RT-PCR) assay testing. He received anti-viral drug, anti-interleukin (IL-6) receptor antagonist and intravenous methylprednisolone. After commencing combined intensive therapy, he showed dramatic improvement of clinical condition, serum biomarkers and radiological findings. Early diagnosis and rapid critical care management may provide meaningful clinical benefit even if severe case.
|
掲載誌名 |
The Journal of Medical Investigation
|
ISSN | 13496867
13431420
|
cat書誌ID | AA11166929
|
出版者 | Tokushima University Faculty of Medicine
|
巻 | 68
|
号 | 1-2
|
開始ページ | 192
|
終了ページ | 195
|
並び順 | 192
|
発行日 | 2021-02
|
出版社版DOI | |
出版社版URL | |
フルテキストファイル | |
言語 |
eng
|
著者版フラグ |
出版社版
|